ALLMedicine™ Irritable Bowel Syndrome Center
Research & Reviews 3,564 results
Inflammopharmacology Pretorius L, Van Staden ADP et. al.
Jan 14th, 2022 - Irritable bowel syndrome (IBS) is a female predominant functional gastrointestinal disorder, underpinned by microbial dysbiosis and microinflammation. We suggest that changes in trace amine (TA) load and metabolism may link together diet, inflamma...
https://doi.org/10.1007/s10620-021-07369-5 10.1053/j.gastro.2020.10.066 10.1053/j.gastro.2016.02.031 10.1136/gut.2006.099929 10.1136/gutjnl-2020-323026 10.1136/gutjnl-2019-318664 10.1136/gutjnl-2019-319281 10.1111/j.1365-2982.2009.01361.x
Digestive Diseases and Sciences; Shah ED
Jan 13th, 2022 - Zinc Deficiency and Intestinal Permeability in the Context of Rational Diagnostic and Drug Development for Diarrhea-Predominant Irritable Bowel Syndrome.|2022|Shah ED,|
Journal of Digestive Diseases; Peng L, Fang J et. al.
Jan 13th, 2022 - Linaclotide demonstrated potency in treating constipation-predominant irritable bowel syndrome (IBS-C), but few studies examined its use in Asian patients. Using data from a completed trial (NCT01880424), this sub-cohort analysis was performed to ...
The American Journal of Gastroenterology; Spiegel BMR, Liran O et. al.
Jan 13th, 2022 - Although gut-directed psychotherapies are effective for IBS, they are rarely prescribed given a paucity of trained clinicians. Virtual reality (VR) offers a solution by allowing patients to self-practice these techniques in a standardized manner. ...
https://doi.org/10.1007/s10787-021-00907-7 10.1016/j.ejphar.2021.174196 10.1016/j.drudis.2020.09.013
Inflammopharmacology Khodabakhsh P, Khoie N et. al.
Jan 12th, 2022 - Irritable bowel syndrome (IBS) is a functional gut disorder with multi-factorial pathophysiology that causes recurring pain or discomfort in the abdomen, as well as altered bowel habits. Montelukast, a well-known cysteinyl leukotriene receptor 1 (...
Guidelines 10 results
Gut Vasant DH, Paine PA et. al.
Apr 28th, 2021 - Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of Gastroenterology (BSG) guideline in 2007, substantial ...
Gastroenterology Quigley EM, Murray JA et. al.
Jul 18th, 2020 - Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implica...
Clinical Gastroenterology and Hepatology : the Official C... Sadowski DC, Camilleri M et. al.
Sep 19th, 2019 - Chronic diarrhea affects about 5% of the population overall. Altered bile acid metabolism is a common but frequently undiagnosed cause. We performed a systematic search of publication databases for studies of assessment and management of bile acid...
Gastroenterology Carrasco-Labra A, Lytvyn L et. al.
Jul 29th, 2019 - The evaluation of patients with chronic watery diarrhea represents a diagnostic challenge for clinicians because organic causes, including inflammatory bowel disease, microscopic colitis, and chronic infection, must be differentiated from function...
Gastroenterology Smalley W, Falck-Ytter C et. al.
Jul 16th, 2019 - AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).|2019|Smalley W,Falck-Ytter C,Carrasco-Labra A,Wani S,Lytvyn L,|standards,diagnosis,etiology,p...
Drugs 239 results see all →
Clinicaltrials.gov 300 results
Jan 12th, 2022 - Recent evidence suggests that in certain clinical conditions - such as chronic low-back pain, migraine, irritable bowel syndrome, attention deficit hyperactivity disorder, and rhinitis - placebos improve clinical outcomes even without deception. P...
Jan 11th, 2022 - The objectives of this study are to evaluate the efficacy, safety and tolerability of ORP-101 in patients with IBS-D. This is a randomized, double-blind, placebo-controlled, 3-arm, 12-week, parallel proof-of-concept study with 2 active arms (50 mg...
Jan 5th, 2022 - This longitudinal study is being done to understand mechanisms underlying development of irritable bowel syndrome (IBS) and the role of the gut bacteria in development of symptoms. This information will be used to determine whether temporal change...
Jan 3rd, 2022 - Approximately one fifth of primary care patients seek care for symptoms that cannot readily be given a medical explanation. In addition, primary care is tasked with offering care for prevalent chronic diseases such as asthma and diabetes where som...
Dec 30th, 2021 - In this prospective study, there is only one group with no placebo/blank control. All qualified IBS-D patients could be admitted to hospital for at least one time of combing therapy (taking rifaximin for 3 days and then receiving fecal microbiota ...
News 590 results
Jan 3rd, 2022 - NEW YORK (Reuters Health) - People with bile acid diarrhea (BAD) may have more permeable intestines than people with irritable bowel syndrome diarrhea (IBS-D), a new study suggests. "This study shows for the first time that patients with biochemic...
Dec 15th, 2021 - Two distinct gut microbiota subtypes showed an enhanced clinical response to a low FODMAP diet in an analysis of 41 adults with irritable bowel syndrome and household controls. Irritable bowel syndrome (IBS) has a significant impact on quality of ...
MDedge Family Medicine; Jose M. Villalon-Gomez, MD, MPH
Nov 12th, 2021 - Irritable bowel syndrome (IBS) continues to pose a diagnostic and therapeutic challenge to clinicians and patients—a challenge that arises from the varying manifestations of the condition, its complex pathophysiology, lack of effective treatment,.
Nov 11th, 2021 - An American Gastroenterological Association clinical practice update for gastrointestinal pain in disorders of gut-brain interaction (DGBI), published in Clinical Gastroenterology and Hepatology, emphasizes patient-physician collaboration and impr...
Nov 8th, 2021 - An American Gastroenterological Association clinical practice update for gastrointestinal pain in disorders of gut-brain interaction (DGBI), published in Clinical Gastroenterology and Hepatology, emphasizes patient-physician collaboration and impr.